TL Genomics
Latest round
- Series B
Last raised
- May 2018
Total raised
- $3.5M
Investors
- 3
About TL Genomics
Founded in 2015 and located in Kanagawa, Japan, TL Genomics Inc. specializes in the creation and distribution of tests and diagnostic agents pertinent to bone marrow transplantation, assessments of disease risk through chromosome analysis, fertility testing, and various other medical care services. In March 2026, TL Genomics Inc. TL Genomics Inc. specializes in innovative biotechnology solutions aimed at age-related health assessments and diagnostics. The company's core offerings include a groundbreaking biological age assessment service utilizing advanced PCR-based chromosome testing technology branded as SinChro™. This technology enables the measurement and estimation of biological markers, providing insights into an individual’s aging process. Additionally, TL Genomics is dedicated to developing in vitro diagnostic products to detect chromosomal abnormalities associated with myelodysplastic syndromes.The revenue model of TL Genomics Inc. is predicated on direct-to-consumer and B2B transactions for its diagnostic services. The company offers its biological age assessment and chromosome testing services through a straightforward transactional structure, where customers can access these services on a per-test basis. The flagship SinChro™ assessment is marketed to both individual clients seeking personal health insights and healthcare institutions looking to incorporate advanced diagnostics into their offerings. This dual approach allows for diverse revenue streams while fostering partnerships within the healthcare sector, thereby establishing a comprehensive ecosystem for its innovative products.
Who invested in TL Genomics
3 investors across 2 rounds
See all investors in TL Genomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about TL Genomics
Who invested in TL Genomics?
TL Genomics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TL Genomics raised?
TL Genomics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did TL Genomics last raise money?
TL Genomics's most recent round on record is a Series B, in May 2018.
What does TL Genomics do?
Founded in 2015 and located in Kanagawa, Japan, TL Genomics Inc.
Where is TL Genomics headquartered?
TL Genomics is headquartered in Fujisawa, Japan.
Which VCs invest in companies like TL Genomics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at TL Genomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like TL Genomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.